Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18756541rdf:typepubmed:Citationlld:pubmed
pubmed-article:18756541lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0038454lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0002895lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0226504lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0020402lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0037198lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0019029lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C0520997lld:lifeskim
pubmed-article:18756541lifeskim:mentionsumls-concept:C1522538lld:lifeskim
pubmed-article:18756541pubmed:issue10lld:pubmed
pubmed-article:18756541pubmed:dateCreated2008-10-1lld:pubmed
pubmed-article:18756541pubmed:abstractTextA 21-year-old man with homozygous sickle cell disease maintained on hydroxyurea for 1 year developed thrombosis of the superior sagittal, right transverse, and right sigmoid dural sinuses with a large venous infarct. He was successfully treated with endovascular thrombolysis. Investigation did not reveal any inherited or acquired hypercoagulable state. This patient however had consistently elevated hemoglobin levels both at the time of the initial event and on follow up. One year later he developed symptomatic avascular necrosis of the right hip. High hemoglobin levels resulting from hydroxyurea therapy may have contributed to development of complications in this patient.lld:pubmed
pubmed-article:18756541pubmed:languageenglld:pubmed
pubmed-article:18756541pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18756541pubmed:citationSubsetIMlld:pubmed
pubmed-article:18756541pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18756541pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18756541pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18756541pubmed:statusMEDLINElld:pubmed
pubmed-article:18756541pubmed:monthOctlld:pubmed
pubmed-article:18756541pubmed:issn1096-8652lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:AbboudMiguel...lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:El...lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:MuwakkitSamar...lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:DabbousIbrahi...lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:Al-KutoubiAgh...lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:SidaniCharif...lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:BallourahWali...lld:pubmed
pubmed-article:18756541pubmed:authorpubmed-author:DahouiHananHlld:pubmed
pubmed-article:18756541pubmed:copyrightInfoCopyright 2008 Wiley-Liss, Inc.lld:pubmed
pubmed-article:18756541pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18756541pubmed:volume83lld:pubmed
pubmed-article:18756541pubmed:ownerNLMlld:pubmed
pubmed-article:18756541pubmed:authorsCompleteYlld:pubmed
pubmed-article:18756541pubmed:pagination818-20lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:meshHeadingpubmed-meshheading:18756541...lld:pubmed
pubmed-article:18756541pubmed:year2008lld:pubmed
pubmed-article:18756541pubmed:articleTitleVenous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: treatment with thrombolysis.lld:pubmed
pubmed-article:18756541pubmed:affiliationDepartment of Radiology, American University of Beirut Medical Center, Beirut, Lebanon.lld:pubmed
pubmed-article:18756541pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18756541pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18756541lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18756541lld:pubmed